HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): David N. Hopkinson Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bhabra, M. S. Articles by Hooper, T. L. Search for Related Content PubMed PubMed Citation Articles by Bhabra, M. S. Articles by Hooper, T. L.

J Thorac Cardiovasc Surg 1997;113:327-334
© 1997 Mosby, Inc.

CARDIAC AND PULMONARY REPLACEMENT

ATTENUATION OF LUNG GRAFT REPERFUSION INJURY BY A NITRIC OXIDE DONOR

Supported by a grant from the National Heart Research Fund, United Kingdom.

Received for publication July 3, 1996 revisions requested August 6, 1996; revisions received August 26, 1996 accepted for publication Sept. 10, 1996. Address for reprints: Timothy L. Hooper, FRCS, MD, Department of Cardiothoracic Surgery, Wythenshawe Hospital, Southmoor Rd., Manchester M23 9LT, United Kingdom.

Abstract

Objective: One of the primary features of ischemia-reperfusion injury is reduced production of protective autocoids, such as nitric oxide, by dysfunctional endothelium. Administration of a nitric oxide donor during reperfusion of lung grafts may therefore be beneficial through modulation of vascular tone and leukocyte and platelet function. Methods: Rat lung grafts were flushed with University of Wisconsin solution and reperfused for 1 hour in an ex vivo model incorporating a support animal. Group I grafts (n = 6) were reperfused immediately after explantation, group II (n = 6) and III (n = 5) grafts after 24 hours of storage at 4° C. In group III, glyceryl trinitrate, a nitric oxide donor, was administered during the first 10 minutes of reperfusion at a rate of 200 µg/min. In an additional group (n = 5), 200 µg/min hydralazine was administered instead, to assess the effect of vasodilation alone. Results: Graft function in group II deteriorated compared with that in group I, with significant reduction of graft effluent oxygen tension and blood flow and elevation of pulmonary artery pressure, peak airway pressure, and wet/dry weight ratio. In contrast, in group III, glyceryl trinitrate treatment improved graft function to baseline levels in all these parameters. Administration of hydralazine, meanwhile, produced mixed results with only two out of five grafts functioning at control levels. Conclusions: In this model, administration of glyceryl trinitrate to supplement the nitric oxide pathway in the early phase of reperfusion has a sustained beneficial effect on lung graft function after 24-hour hypothermic storage, probably through mechanisms beyond vasodilation alone.

This article has been cited by other articles:

				M. Wu, Q. Yang, A. P.C. Yim, M. J. Underwood, and G.-W. He Cellular electrophysiologic and mechanical evidence of superior vascular protection in pulmonary microcirculation by Perfadex compared with Celsior. J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 492 - 498. [Abstract] [Full Text] [PDF]

				M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF]

				M. KAWASHIMA, T. BANDO, T. NAKAMURA, N. ISOWA, M. LIU, S. TOYOKUNI, S. HITOMI, and H. WADA Cytoprotective Effects of Nitroglycerin in Ischemia-Reperfusion-Induced Lung Injury Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 935 - 943. [Abstract] [Full Text] [PDF]

				B. Prendergast, D.H.T. Scott, and P.S. Mankad Beneficial effects of inhaled nitric oxide in hypoxaemic patients after coronary artery bypass surgery Eur. J. Cardiothorac. Surg., November 1, 1999; 14(5): 488 - 493. [Abstract] [Full Text] [PDF]